Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$21,431,111
in 18 filings, $21.0M under 10b5-1 plans

Net −$21,431,111. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-12 Dambkowski Carl Director Sale 10b5-1 −12,583 $70.11 $882K 38,743
2026-06-11 Dambkowski Carl Director Sale 10b5-1 −22,417 $70.13 $1.6M 51,326
2026-06-02 Dambkowski Carl Director Grant or award · Stock Option (right to buy) +9,136 9,136
2026-05-21 Dambkowski Carl Director Exercise or conversion 10b5-1 +38,689 $6.84 $265K 155,172
2026-05-21 Dambkowski Carl Director Exercise or conversion 10b5-1 +11,904 $7.80 $93K 167,076
2026-05-21 Dambkowski Carl Director Exercise or conversion 10b5-1 +11,667 $11.77 $137K 178,743
2026-05-21 Dambkowski Carl Director Sale 10b5-1 −38,318 $58.43 $2.2M 140,425
2026-05-21 Dambkowski Carl Director Sale 10b5-1 −53,447 $59.10 $3.2M 86,978
2026-05-21 Dambkowski Carl Director Sale 10b5-1 −13,235 $59.97 $794K 73,743
2026-05-21 Dambkowski Carl Director Exercise or conversion · Stock Option (right to buy) 10b5-1 −38,689 32,737
2026-05-21 Dambkowski Carl Director Exercise or conversion · Warrant (right to buy) 10b5-1 −11,904 10,952
2026-05-21 Dambkowski Carl Director Exercise or conversion · Stock Option (right to buy) 10b5-1 −11,667 5,833
2026-01-23 Dambkowski Carl Director Other acquisition +116,483 116,483
2025-06-02 Dambkowski Carl Director Grant or award · Stock Option (right to buy) +17,500 17,500

Page 1 of 1 · 14 trades